Cannara Biotech Inc.
Market Cap
$181.03M
P/E Ratio
15.75
EPS
$0.12
Dividend Yield
0.00%
52-Week Range
$1.06 — $2.07
Volume
63.18K
Avg Volume
50.21K
Beta
0.34
P/E (TTM)
15.75
Forward P/E
11.12
PEG Ratio
-1.05
P/S (TTM)
1.61
P/B (TTM)
1.59
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.12%
ROA (TTM)
0.07%
ROIC
—
Gross Margin
0.39%
Operating Margin
0.14%
Net Margin
—
Debt/Equity
0.31
Current Ratio
2.70
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.95%
EPS Growth (5Y)
+1.05%
Sales Growth (3Y)
+0.45%
Sales Growth (5Y)
+1.62%
EPS Est (This Year)
$0.17
EPS Est (Next Year)
$0.20
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.18
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
95.78M
Float
42.47M
Free Float %
44.34%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
CA
Exchange
TSXV
IPO Date
2019-01-14
Employees
461
CEO
Zohar Krivorot
Index Membership
—
Website
https://cannara.ca
Cannara Biotech Inc. (LOVE.V) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the TSXV. With a market capitalization of $181.03M, a P/E ratio of 15.75, LOVE.V is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare LOVE.V against other stocks using dozens of fundamental and technical filters.
Cannara Biotech Inc. (LOVE.V) has a trailing twelve-month (TTM) P/E ratio of 15.75. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Cannara Biotech Inc. (LOVE.V) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Cannara Biotech Inc. (LOVE.V) has a market capitalization of $181.03 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.